Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Australian Clinical Labs Limited as documented in a recent Form 605 filing. The form, dated 12 April 2024, details various transactions involving the purchase and sale of fully paid ordinary shares by entities controlled by Mitsubishi UFJ and First Sentier Investors Holdings Pty Ltd over March 2024. These changes reflect significant shifts in share ownership and voting power within the company.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
